
Medicines and Healthcare products Regulatory Agency
Medicines and Healthcare products Regulatory Agency (MHRA) takes decisive action to phase out animal testing by helping developers to make greater use of New Approach Methodologies (NAMs).
MHRA Products | Home
We publish the most up-to-date information for a medicine according to its licence history. You can use the A-Z list to find an active substance, or search for a medicine. We publish scientific...
Clinical trials regulations reform - Health Research Authority
Apr 9, 2026 · Transforming the UK's clinical trial landscape The UK's clinical trial regulations are changing. The Health Research Authority (HRA) has been working in partnership with the Medicines …
ance report Chair’s foreword As Chair of the Medicines and Healthcare products Regulatory Agency (MHRA), I am pleased to present our ann. al report for the year 2024/25. This year has been marked...
Home Page | MHRA
MHRA-GMDP contains information relating to manufacturing and wholesale distribution authorisations, API registrations and GMP/GDP certificates. Notified E-cigarette products published for supply...
Medicines and Healthcare products Regulatory Agency
The MHRA was established in 2003 through the merger of the Medicines Control Agency (MCA) and the Medical Devices Agency (MDA). The creation of a single regulator was intended to streamline …
MHRA Updates Clinical Investigation Guidance and Launches …
MHRA Updates Guidance on Clinical Investigations and Introduces 2026–2027 Fee Waiver Pilot The UK Medicines and Healthcare products Regulatory Agency (MHRA) has updated its guidance on how to …
Bayer wins MHRA approval for Kerendia in heart failure
Apr 13, 2026 · Bayer has received MHRA approval for Kerendia (finerenone) for adults in the UK with symptomatic chronic heart failure and a left ventricular ejection fraction of 40% or above.
Blood pressure medication recall announced by MHRA
2 days ago · Dr Alison Cave, MHRA chief safety officer, said: ‘If you take Ramipril 10mg, check the packaging for batch number GR174091. The batch number and expiry date information can be found …
MHRA Approves Olezarsen for Rare Lipid Disorder - Medscape
Apr 13, 2026 · The MHRA has approved olezarsen for familial chylomicronaemia syndrome, a rare disorder linked to life-threatening pancreatitis.